Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

NCT01561911

Conditions
B-Cell, Cancer, Hemic and Lymphatic Diseases, +8 more
Locations
  • Cancer Research UK Institute for Cancer Studies, University of Birmingham Edgbaston, Birmingham, United Kingdom
  • Cancer Research UK Medical Oncology Unit, Southampton General Hospital Tremona Road,, Southampton, United Kingdom
View Trial Details
Completed

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT00513955

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Good Hope Hospital Birmingham, England, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, England, United Kingdom
  • Blackpool Victoria Hospital Blackpool, England, United Kingdom
View all 25 locations
View Trial Details
Completed

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

NCT00891137

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +59 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
View Trial Details
Completed

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

NCT00109928

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente - Fremont Fremont, California, United States
  • Kaiser Permanente Medical Center - Hayward Hayward, California, United States
View all 77 locations
View Trial Details
Completed

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

NCT00357500

Conditions
Central Nervous System Neoplasms, Central Nervous System Tumor, Pediatric, Hematologic Diseases, +23 more
Locations
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Miami Children's Hospital Miami, Florida, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Maine Medical Center Research Institute Scarborough, Maine, United States
View Trial Details
Completed

Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma

NCT00059839

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 159 locations
View Trial Details

Related conditions